Latest risk assessment
 |
Multi-country outbreak of multiple Salmonella enterica serotypes linked to imported sesame based products
Date of publication: 14 October 2021 Since January 2019, 121 cases of Salmonella enterica infections with six different serotypes linked to sesame-based products have been reported in five EU/EEA countries. The serotypes are S. Amsterdam, S. Havana, S. Kintambo, S. Mbandaka, S. Orion, and S. Senftenberg.
|
Technical reports on COVID-19
 |
Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update
Date of publication: 28 October 2021 This document outlines the key steps for contact tracing in the context of the COVID-19 response, including contact identification, advice, and follow-up.
|
|
|
Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK – first update
Date of publication: 26 October 2021 This report aims to facilitate further discussions between Member States on the settings and purpose for which it is appropriate to use rapid antigen detection tests (RADTs) and summarises key considerations for their implementation.
|
|
 |
COVID-19 surveillance guidance – Transition from COVID-19 emergency surveillance to routine surveillance of respiratory pathogens
Date of publication: 18 October 2021 This publication offers practical guidance to EU/EEA countries, encouraging them to transition from emergency surveillance for COVID-19 to more sustainable, objective-driven, surveillance systems.
|
|
 |
Facilitating COVID-19 vaccination acceptance and uptake in the EU/EEA
Date of publication: 15 October 2021 This report aims to support Member States in identifying barriers to the uptake of COVID-19 vaccination, and designing and implementing interventions aimed at increasing vaccination coverage. While 74% of people aged 18 and over in the EU/EEA are currently fully vaccinated, coverage is far from equal across countries.
|
|
|
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study
Date of publication: 8 October 2021 This document reports the first interim pooled estimates from the ECDC study of COVID-19 vaccine effectiveness (VE)
|
|
|
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, version 1.0
Date of publication: 8 October 2021 This protocol is intended to guide the implementation of ECDC-funded studies but can also be used as a basis for other vaccine effectiveness studies in countries/hospitals that do not currently plan to participate in ECDC-funded studies.
|
|
| Technical reports on other topics | ||
 |
Response plan to control and manage the threat of multi-and extensively drug-resistant gonorrhoea in Europe – Indicator monitoring 2019
Date of publication: 19 October 2021 This report reviews the progress made over the preceding two years in the ECDC response plan to control and manage drug-resistant gonorrhoea, using the data collected for 2019.
|
|
| Surveillance reports | ||
 |
Influenza virus characterisation – September 2021
Date of publication: 22 October 2021 This is the 10th and final report for the 2020-2021 influenza season. As of week 39/2021, only 1 276 influenza detections across the WHO European Region were reported to TESSy; 60% type A viruses, with A(H3N2) (85%) dominating over A(H1N1)pdm09 (15%), and 40% type B viruses, with only 16 having been ascribed to a lineage, 15 B/Victoria and one B/Yamagata.
|
|
 |
Annual Epidemiological Report series on communicable diseases in Europe
The Annual Epidemiological Report series on communicable diseases in Europe provides a comprehensive summary of surveillance data for EU/EEA countries. It is mainly intended for public health professionals and policymakers involved in infectious disease prevention and control.
Published in October:
|
|
 |
ECDC communicable disease threats report
Date of publication: every Friday The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control. Summarising information gathered by ECDC through its epidemic intelligence activities regarding communicable disease threats of concern to the European Union, it also provides updates on the global situation and changes in the epidemiology of communicable diseases with potential to affect Europe, including diseases that are the focus of eradication efforts.
|
|
| Scientific peer-reviewed publications | ||
 |
Publications by ECDC staff in scientific journals
All scientific peer-reviewed publications produced by ECDC staff on behalf of the Centre for the period January 2005 – December 2020 are available online.
|
|